Oxycodone News and Research

RSS

Endo recalls two lots of Endocet Tablets

Endo Pharmaceuticals today issued a voluntary nationwide consumer level recall of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70, Lot # 402415NV and #402426NV.

27 Jun 2011

FDA issues Complete Response Letter for Pfizer's REMOXY NDA

DURECT Corporation today reported that Pfizer Inc. has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for REMOXY, a controlled-release form of oxycodone designed to discourage common methods of tampering.

27 Jun 2011

Pfizer and Pain Therapeutics receive FDA Complete Response Letter for resubmission of REMOXY NDA

Pfizer and Pain Therapeutics, Inc. announced that a Complete Response Letter was received from the U.S. Food and Drug Administration (FDA) on the resubmission to the new drug application (NDA) for REMOXY® (oxycodone) Extended-Release Capsules CII. Pfizer is working to evaluate the issues described in the Complete Response Letter and plans to have further discussions with FDA around them.

24 Jun 2011

New anti-abuse formulation of painkiller Oxycodone

It has come to health officials’ attention nationwide that there is a serious rise of abuse of painkillers, especially opioids. Federal officials recently stepped up plans to monitor frequent prescribers and users.

21 Jun 2011

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM Tablets CII.

20 Jun 2011

Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose

Deaths related to prescription opioid therapy are under intense scrutiny, prompting those in pain medicine-clinicians, patient advocates, and regulators-to understand the causes behind avoidable mortality in legitimately treated patients.

13 Jun 2011

Panel votes 20-0 for reformed labeling of kids’ pain & fever relieving medication

A federal advisory panel unanimously recommended that dosing for children's acetaminophen be based primarily on the child's weight rather than age. At present the dosing for children's products including acetaminophen- best known by the brand name Tylenol- is based on age, although many labels also contain information on dosing by weight as well. Acetaminophen is the most commonly used medicine meant to lower fever and relieve pain in children.

19 May 2011

Mylan launches Oxycodone and Aspirin Tablets for treatment of severe pain

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with licensing partner Coastal Pharmaceuticals.

5 May 2011

Marijuana licensing laws vetoed by Washington Governor

Current laws regarding marijuana have come under the scanner. US attorneys have warned states that those who are licensed to grow marijuana or even those who regulate it could be subjected to prosecution. Because of this, several states have begun to change their existing laws for medical marijuana.

4 May 2011

Facts become greatest casualty in war on pain medications

The Florida Society of Pain Management Providers urges Government, Law Enforcement and the media to stop using false prescription drug data and statistics. The continued release of false and / or out of context information is solely intended to enflame the public. The misinformation that unfairly portrays Florida as ground zero in this issue has significant consequences for pain management patients and the physicians who provide legitimate care.

22 Apr 2011

Viewpoints: Gov. Walker on 'obsolete' Medicaid; Are patients consumers?; The Onion pokes fun at Romney

What does Medicaid have in common with "I Dream of Jeannie," "Lost in Space" and "Get Smart"? They all made their debut in 1965. ... the television networks have updated their programming.

22 Apr 2011

Feds announce comprehensive plan to combat painkiller abuse

The new strategy will put increased pressure on the state of Florida, which has a reputation as being "the nation's pill mill."

21 Apr 2011

Plans to combat painkiller abuse

This Tuesday, the Obama administration announced a plan to fight prescription drug abuse, warning that accidental fatal overdoses now exceed the combined deadly overdoses from the crack epidemic of the 1980s and black tar heroin in the 1970s.

19 Apr 2011

QRxPharma receives new U.S. Patent for MoxDuo IR in treatment of acute pain

QRxPharma Limited announced today that the United States Patent and Trademark Office issued the Company a new patent, U.S. Patent #7,923,453, which expires in 2029. This patent covers a proprietary dosing algorithm for converting patients from intravenous opioid administration to orally administered MoxDuo IR, thereby more effectively and safely managing acute pain following surgery.

15 Apr 2011

Two reports show drastic increase in opioid prescriptions in America

Two reports by addiction researchers at the University of Pennsylvania School of Medicine and the National Institute on Drug Abuse show a drastic shift in prescribing patterns impacting the magnitude of opioid substance abuse in America.

6 Apr 2011

Research links frequent prescribing to opioid-related deaths

Some physicians are prescribing opioids such as OxyContin 55 times as often as others, according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). The study found most opioid-related deaths occur among patients treated by physicians who frequently prescribe opioids, suggesting doctors who prescribe a lot of opioids may not be doing so safely.

15 Mar 2011

New concerns over prescription narcotics use

Over fifty Australian general practitioners have come under the scanner as part of a national crackdown on inappropriate prescribing of narcotics. The three-month campaign is being carried out by the Medicare following high levels of prescriptions for drugs such as OxyContin and OxyNorm. One GP has been found to be writing over 90 per cent of their prescriptions for narcotics. There are further concerns that the painkillers are being resold on the black market.

7 Mar 2011

FDA's action impacts Elite pharma drugs

Elite Pharmaceuticals, Inc. advises that the US Food and Drug Administration announced that it intends to remove approximately 500 cough/cold and allergy related products from the U.S. market.

7 Mar 2011

Viewpoints: Judge Kessler's decision; Utah is role model; Malpractice system flaws

The Republican strategy is to split the vast middle and working classes -- pitting unionized workers against nonunionized, public-sector workers against nonpublic, older workers within sight of Medicare and Social Security against younger workers who don't believe these programs will be there for them and the poor against the working middle class.

28 Feb 2011

UBC study shows Canadians and Americans receive different drug information online

Americans and Canadians are getting vastly different search results when they look up prescription drug information online, says a study by researchers at the University of British Columbia.

24 Feb 2011